Klor Con M
- Product NDC
- 0615-3599
- 11-digit product format
- 006153599
- Labeler code
- 0615
- Product ID
- 0615-3599_f4616553-a74b-44cc-89f1-7772bb2c7bac
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- potassium chloride
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- NCS HealthCare of KY, Inc dba Vangard Labs
- Application
- ANDA074726
- Marketing category
- ANDA
- Marketing start
- 1998-11-20
- Marketing end
- 0000-00-00
- Substance
- POTASSIUM CHLORIDE
- Active strength
- 1500 mg/1
- Pharmacologic classes
- Potassium Compounds [CS],Potassium Salt [EPC],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA]
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 0615-3599-05 | 2022-03-15 | C162847 | 48780-1 | 9d75b9d0-3ebf-f424-e053-dadaa90a57ce | 45334459-6117-42c5-9588-db1d6eb57418 |
| 0615-3599-30 | 2022-03-15 | C162847 | 48780-1 | 9d75b9d0-3ebf-f424-e053-dadaa90a57ce | 45334459-6117-42c5-9588-db1d6eb57418 |
| 0615-3599-31 | 2022-03-15 | C162847 | 48780-1 | 9d75b9d0-3ebf-f424-e053-dadaa90a57ce | 45334459-6117-42c5-9588-db1d6eb57418 |
| 0615-3599-39 | 2022-03-15 | C162847 | 48780-1 | 9d75b9d0-3ebf-f424-e053-dadaa90a57ce | 45334459-6117-42c5-9588-db1d6eb57418 |
| 0615-3599-05 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-3ebf-f424-e053-dadaa90a57ce | 45334459-6117-42c5-9588-db1d6eb57418 |
| 0615-3599-30 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-3ebf-f424-e053-dadaa90a57ce | 45334459-6117-42c5-9588-db1d6eb57418 |
| 0615-3599-31 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-3ebf-f424-e053-dadaa90a57ce | 45334459-6117-42c5-9588-db1d6eb57418 |
| 0615-3599-39 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-3ebf-f424-e053-dadaa90a57ce | 45334459-6117-42c5-9588-db1d6eb57418 |